LAUSR

First stakeholders meeting held at the Wellcome Trust in London, UK, followed by a Funder's forum. European AIDS Vaccine Initiative (EAVI2020) and the European HIV Vaccine Alliance (EHVA) are funded by the European Commission to foster a multidisciplinary approach to HIV vaccine development. 2016 HVTN 702 (Uhambo) launched to test whether a new version of the RV144 HIV vaccine candidate safely prevents HIV infection among adults in South Africa. 2017 Launched of the HVTN 705 (Imbokodo) trial, a Phase 2b proof-of-concept study in HIV-negative women in Africa evaluating the safety and efficacy of an experimental regimen based on a “mosaic” vaccine designed to induce immune responses against a wide variety of global HIV strains. 2018 Enterprise transfers to the International AIDS Society (IAS). Abbreviations: AVAC, AIDS Vaccine Advocacy Coalition;NIH, National Institutes of Health;UNAIDS, The Joint United Nations Programme on HIV/AIDS;R&D, reseach and development;US-MHRP, U.S. Military HIV Research Program;WHO, World Health Organization. [...]the Global HIV Vaccine Enterprise was established in 2005 [ 6].